Patents by Inventor Martin Howard Osterhout

Martin Howard Osterhout has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinazoline ditosylate salt compounds
    Patent number: 7157466
    Abstract: Ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorde4rs characterized by aberrant erbB family PTK activity.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: January 2, 2007
    Assignee: SmithKline Beecham (Cork) Limited
    Inventors: Michael Scott McClure, Martin Howard Osterhout, Frank Roschangar, Mark Joseph Sacchetti
  • Methods of treating periodontal disease
    Patent number: 6770267
    Abstract: The present invention relates to methods of treating periodontal disease.
    Type: Grant
    Filed: March 26, 2002
    Date of Patent: August 3, 2004
    Assignee: SmithKline Beecham Corporation
    Inventors: Susan Mary Daluge, Cynthia Holder Jurgensen, Michael Tolar Martin, Martin Howard Osterhout
  • Methods of treating periodontal disease
    Publication number: 20040034020
    Abstract: The present invention relates to methods of treating periodontal disease.
    Type: Application
    Filed: February 3, 2003
    Publication date: February 19, 2004
    Inventors: Susan Mary Daluge, Cynthia Holder Jurgensen, Michael Tolar Martin, Martin Howard Osterhout
  • Quinazoline ditosylate salt compounds
    Publication number: 20030220354
    Abstract: Ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
    Type: Application
    Filed: March 31, 2003
    Publication date: November 27, 2003
    Inventors: Michael Scott McClure, Martin Howard Osterhout, Frank Roschangar, Mark Joseph Sacchetti
  • Phenyl xanthine derivatives
    Patent number: 6608069
    Abstract: The present invention relates to novel compounds of formula (I): wherein Z represents a 5 or 6 membered cycloalkyl, aryl, substituted cycloalkyl, or substituted aryl, said cycloalkyl, aryl, substituted cycloalkyl or substituted aryl optionally containing one or more heteroatoms selected from 0, N or S; k represents 0 or 1; n represents an integer of 1 to 50; X represents —O—, —N(H)—, —N(C1-6alkyl)-, —N(C3-8cycloalkyl)-, —N(C1-8alkyl)(C3-8 cycloalkyl), —N[(CH2CH2O)m(C1-12 alkyl, aryl, or aralkyl)]-, —CH2O—, —CH2NH—, —CH2N(C1-6alkyl)-, —CH2N(C3-8cycloalkyl)-, or —C1-12alkyl-; Q represents (—CH2)p, (—CH═CH—)p, (—C≡C—)p, (—(O)p1CH2—)p or (—CH2(O)p1)p R6 and R7 independently represent O or S; and all other variables are as defined herein; processes for their preparation, pharmaceutical formulations containing them, and their use in me
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: August 19, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Susan Mary Daluge, Michael Tolar Martin, Martin Howard Osterhout
  • Methods of treating periodontal disease
    Publication number: 20030032804
    Abstract: The present invention relates to novel compounds of formula (I): processes for their preparation, pharmaceutical formulations containing them, and their use in medicine, particularly in the prophylaxis and treatment of inflammatory conditions, immune disorders, septic shock circulatory disorders, and gastrointestinal inflammation and disorders.
    Type: Application
    Filed: March 26, 2002
    Publication date: February 13, 2003
    Inventors: Susan Mary Daluge, Cynthia Holder Jurgensen, Michael Tolar Martin, Martin Howard Osterhout